The European Alliance of Associations for Rheumatology (EULAR) has updated its recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. For the 2023 ...

Boumpas D. EULAR-Recommendations on the management of lupus. Presented at: EULAR 2023 Congress; May 31 to June 3, 2023, Milan, Italy. Disclosures: Boumpas reported no relevant financial disclosures.

About 200,000-300,000 people live with SLE in the U.S., and about one-third of these people are diagnosed with lupus nephritis at the time of their SLE diagnosis. About 50 percent of all people ...

Fate Therapeutics, Inc. (NASDAQ:FATE) is among the best get rich quick stocks to buy now. Analysts at H.C. Wainwright have ...

EULAR has released new recommendations for non-pharmacologic management of lupus and systemic sclerosis. The new guideline includes recommendations encouraging physical exercise for patients with ...

HSS Study at EULAR 2025 Congress Uses an AI Model to Predict Readmissions of Pregnant Women with Lupus Based on Social Determinants of Health Provided by Business Wire Jun 14, 2025, 12:00:00 PM ...

TORONTO, June 10, 2020 (GLOBE NEWSWIRE) -- Eli Lilly and Company presented new data for OLUMIANT® (baricitinib) at the virtual European Congress of Rheumatology (EULAR 2020). Highlights from ...

The EULAR/ERA-EDTA developed updated recommendations for the management of lupus nephritis. Based on emerging new evidence and expert consensus, a multidisciplinary task force put together by the ...

Cite this: EULAR 2009: Intravenous Cyclophosphamide Superior to Oral Cyclophosphamide as Induction Therapy in Lupus Nephritis - Medscape - Jun 19, 2009. Authors and Disclosures Journalist ...

Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting showing that an artificial intelligence (AI)-based ...